In the biopharmaceutical industry, there are grand promises of making clinical trials easier for sites and patients, but in reality, many of these promises are not fulfilled. Sponsors often implement complicated plans for collecting biospecimens and managing samples, making the process more difficult. Centricity, which is supposed to prioritize the needs of trial sites and participants, is often reduced to superficial gestures like prompt payments and the use of tablets for surveys. The true essence of centricity lies in addressing the unseen complexities of clinical trials and providing real solutions that focus on the needs of those involved.
Source link
Unmasking the ‘centricity’ illusion in clinical trials
